MHRA Releases New Pre-Market Regulatory Requirements for Medical Devices
TL/DR –
The Medicines and Healthcare products Regulatory Agency (MHRA) has released new pre-market regulatory requirements for medical devices and in vitro diagnostic devices in the British market. These requirements aim to provide quicker access to safe and innovative medical devices, supporting economic growth and innovation in the medtech sector, and outline a structured approach for quick access for devices approved in Australia, Canada, and the US. The draft regulations will require healthcare organizations to give patients implant cards about the implanted device, make Unique device identifiers (UDI) mandatory for precise identification and traceability of devices throughout their lifecycle, and align classifications of in vitro diagnostic (IVD) devices and essential requirements for medical devices with international standards.
The Medicines and Healthcare products Regulatory Agency sets new pre-market rules for medical devices
New pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the British market have been published by the Medicines and Healthcare products Regulatory Agency (MHRA). The requirements provide an opportunity for World Trade Organization members to comment on the draft rules, known as the draft Medical Devices (Amendment) Regulations 2026. Feedback from the medtech industry, approved bodies, healthcare providers, and patients is also sought.
These responses will shape the Impact Assessment and future implementation of the regulations. The draft rules aim to facilitate faster access to safe and innovative medical devices, support economic growth in the medtech sector, and provide a framework for quicker access for devices approved by Australia, Canada, and the US’s regulators.
The updated regulations mandate healthcare organisations to provide patients with implant cards containing information about the implanted medical device. This measure enhances the capacity to handle adverse events and provides transparency for patients. Compulsory unique device identifiers (UDI) will ensure accurate identification and traceability of devices throughout their lifecycle.
The new classifications will bring in vitro diagnostic (IVD) devices in line with the standards of the International Medical Device Regulators Forum (IMDRF) and align Great Britain’s essential requirements for medical devices with best international practice. As reported previously, the government plans to amend medical device regulations to include EU Common Specifications for high-risk IVD devices.
—
Read More Health & Wellness News ; US News